Genomadix Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Early Stage VC
- Investors
-
12
Genomadix General Information
Description
Developer of a molecular test technology designed to facilitate biological testing in the areas of infectious diseases, precision medicine, and water safety. The company has developed a diagnostic platform as well as a portable molecular analyzer that uses polymerase chain reaction (PCR) technology to generate quick, accurate test results outside of a healthcare facility, enabling doctors and patients to get access to rapid diagnostics required for real-time healthcare decisions.
Contact Information
Website
www.genomadix.comCorporate Office
- 340 Legget Drive
- Suite 180
- Kanata, Ontario K2K 2A4
- Canada
Corporate Office
- 340 Legget Drive
- Suite 180
- Kanata, Ontario K2K 2A4
- Canada
Genomadix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 29-Aug-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 25-Aug-2022 | $5.78M | Completed | Generating Revenue | ||
| 1. Seed Round | 19-Jul-2022 | $5.78M | $5.78M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Genomadix Patents
Genomadix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210054439-A1 | Linearly-amplified internal control for nucleic acid amplification reaction | Inactive | 16-Mar-2018 | ||
| US-20220282302-A1 | Linearly-amplified internal control for nucleic acid amplification reaction | Inactive | 16-Mar-2018 | ||
| US-12060548-B2 | Fluid handling apparatus | Active | 19-Jan-2018 | ||
| US-20200339928-A1 | Fluid handling apparatus | Active | 19-Jan-2018 | ||
| US-D871607-S1 | Concentration detector for laboratory use | Active | 24-Oct-2017 |
Genomadix Signals
Genomadix Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Cliffbrake | Family Office | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Maple Leaf Angels | Angel Group | Minority |
Genomadix FAQs
-
When was Genomadix founded?
Genomadix was founded in 2021.
-
Where is Genomadix headquartered?
Genomadix is headquartered in Kanata, Canada.
-
What is the size of Genomadix?
Genomadix has 38 total employees.
-
What industry is Genomadix in?
Genomadix’s primary industry is Diagnostic Equipment.
-
Is Genomadix a private or public company?
Genomadix is a Private company.
-
What is Genomadix’s current revenue?
The current revenue for Genomadix is .
-
How much funding has Genomadix raised over time?
Genomadix has raised $5.78M.
-
Who are Genomadix’s investors?
, Cliffbrake, , , and Maple Leaf Angels are 5 of 12 investors who have invested in Genomadix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process